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The susceptibility of the mammary gland to carcinogenesis is influenced by its normal development, particularly during
developmental stages such as puberty and pregnancy that are characterized by marked changes in proliferation and
differentiation. Protein kinases are important regulators of proliferation and differentiation, as well as of neoplastic
transformation, in a wide array of tissues, including the breast. Using a RT-PCR-based cloning strategy, we have identified
41 protein kinases that are expressed in breast cancer cell lines and in the murine mammary gland during development. The
expression of each of these kinases was analyzed throughout postnatal mammary gland development as well as in a panel
of mammary epithelial cell lines derived from distinct transgenic models of breast cancer. Although the majority of protein
kinases isolated in this screen have no currently recognized role in mammary development, most kinases examined were
found to exhibit developmental regulation. After kinases were clustered on the basis of similarities in their temporal
expression profiles during mammary development, multiple distinct patterns of expression were observed. Analysis of these
patterns revealed an ordered set of expression profiles in which successive waves of kinase expression occur during
development. Interestingly, several protein kinases whose expression has previously been reported to be restricted to tissues
other than the mammary gland were isolated in this screen and found to be expressed in the mammary gland. In aggregate,
these findings suggest that the array of kinases participating in the regulation of normal mammary development is
considerably broader than currently appreciated. © 2000 Academic Press
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Numerous epidemiologic and animal studies analyzing
the impact of reproductive events such as puberty, preg-
nancy, and parity on early events in carcinogenesis suggest
that the developmental state of the breast plays a critical
role in the determination of breast cancer risk (Lambe et al.,
994; MacMahon et al., 1970, 1982; Newcomb et al., 1994;
Russo and Russo, 1978, 1987). This implies an intrinsic
relationship between the process of carcinogenesis and
normal pathways of differentiation and development in the
breast. Therefore, understanding the mechanisms by which
reproductive events influence breast cancer susceptibility
will undoubtedly require an improved understanding of
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All rights of reproduction in any form reserved.normal mammary development, particularly with respect
to genes that control mammary proliferation and differ-
entiation.
Protein kinases represent the largest class of genes known
to regulate differentiation, development, and carcinogen-
esis in eukaryotes. Therefore, we have chosen to study
members of this family of regulatory proteins as one ap-
proach to elucidating the relationship between develop-
ment and carcinogenesis in the breast. Several protein
kinases have been implicated in the development of breast
cancer either in humans or in rodent model systems. For
instance, the EGF receptor and ErbB2/HER2 are each am-
plified and overexpressed in subsets of highly aggressive
breast cancers, and these molecules may thereby provide
prognostic information relevant to clinical treatment and
outcome (Klijn et al., 1993; Slamon et al., 1987, 1989).
Furthermore, overexpression of specific protein kinases, or259
G260 Chodosh et al.of ligands for protein kinases, in the mammary epithelium
of transgenic animals results in neoplastic transformation
(Cardiff and Muller, 1993; Guy et al., 1994; Muller et al.,
1988, 1990). Finally, by analogy with hematopoiesis, some
protein kinases are likely to be expressed in a lineage-
restricted manner in the breast and as such may provide
insight into biologically meaningful subpopulations of cells
(Dymecki et al., 1990; Siliciano et al., 1992; Tsukada et al.,
1993). These findings suggest that further analysis of pro-
tein kinase function may reveal significant features of the
relationship between development and carcinogenesis in
the breast, as well as provide insight into how the decision
to proliferate or differentiate is made in mammary epithe-
lial cells.
In light of the importance of this class of regulatory
molecules, we initiated a systematic study of the role of
protein kinases in mammary gland development and carci-
nogenesis. Examination of 1450 cDNA clones generated
using a RT-PCR-based screening strategy identified 41
protein kinases, including 33 tyrosine kinases and 8 serine/
threonine kinases, 3 of which were novel. The expression of
these kinases was subsequently examined during defined
stages in mammary development and in a panel of mam-
mary tumor cell lines derived from distinct transgenic
models of breast cancer. Our findings reveal an ordered
series of protein kinase expression patterns that occur
during each of the stages of postnatal mammary develop-
ment, suggesting that these molecules may be important
regulators of this process.
MATERIALS AND METHODS
Cell Culture
Mammary epithelial cell lines were derived from mammary
tumors or hyperplastic lesions that arose in MMTV-c-myc,
MMTV-int-2, MMTV-neu/NT, or MMTV-Ha-ras transgenic mice
and included: the neu transgene-initiated mammary tumor-derived
cell lines SMF, NAF, NF639, NF11005, and NK-2; the c-myc
transgene-initiated mammary tumor-derived cell lines 16MB9a,
8Ma1a, MBp6, M158, and M1011; the Ha-ras transgene-initiated
mammary tumor-derived cell lines AC816, AC236, and AC711; the
int-2 transgene-initiated hyperplastic cell line HBI2; and the int-2
transgene-initiated mammary tumor-derived cell line 1128 (Morri-
son and Leder, 1994). Additional cell lines were obtained from
ATCC and included NIH3T3 cells and the nontransformed murine
mammary epithelial cell lines NMuMG and CL-S1. All cells were
cultured under identical conditions in DMEM medium supple-
mented with 10% bovine calf serum, 2 mM L-glutamine, 100
units/ml penicillin, and 100 mg/ml streptomycin.
Animals and Tissues
FVB mice were housed under barrier conditions with a 12-h
light/dark cycle. The mammary glands from between 10 and 40
age-matched mice were pooled for each developmental point. Mice
for pregnancy points were mated at 4–5 weeks of age. Mammary
gland harvest consisted in all cases of the No. 3, 4, and 5 mammary
glands. The lymph node embedded in the No. 4 mammary gland
was removed prior to harvest. Tissues used for RNA preparationCopyright © 2000 by Academic Press. All rightwere snap frozen on dry ice. Tissues used for in situ hybridization
analysis were embedded in OCT medium and frozen in a dry
ice/isopentane bath. Developmental expression patterns for 13
kinases were confirmed using independent pools of RNA. Analysis
of the developmental expression pattern for an additional kinase
using these independent pooled samples revealed a similar
pregnancy-upregulated expression pattern that differed with re-
spect to the day of pregnancy at which maximal upregulation
occurred.
Construction and Analysis of Kinase-Specific
cDNA Libraries
Kinase-specific cDNA libraries were constructed using mRNA
prepared from the mammary glands of mice at specified stages of
development and from a panel of mammary epithelial cell lines.
Specifically, total RNA was prepared from the mammary glands of
either 5-week-old nulliparous female mice or parous mice that had
undergone a single pregnancy followed by 21 days of lactation and
2 days of postlactational regression. Total RNA was also prepared
from the mammary epithelial cell lines NMuMG, CL-S1, HBI2,
SMF, 16MB9a, AC816, and 1128, described above.
First-strand cDNA was generated from each of these nine
sources of RNA using the cDNA Cycle kit according to the
manufacturer’s directions (Invitrogen). These were amplified using
degenerate oligonucleotide primers corresponding to conserved
regions in kinase catalytic subdomains VI and IX. The degenerate
primers, PTKIa (59-GGGCCCGGATCCAC(A/C)G(A/G/C/T)GA-
(C/T)(C/T)-39) and PTKIIa (59-CCCGGGGAATTCCA(A/T)AGG-
ACCA(G/C)AC(G/A)TC-39), have previously been shown to am-
plify a conserved 200-bp portion of the catalytic domain of a wide
variety of tyrosine kinases (Wilks, 1989, 1991; Wilks et al., 1989).
Two additional degenerate oligonucleotide primers, BSTKIa (59-
GGCCCGGATCC(G/A)T(A/G)CAC(A/C)G(A/G/C)GAC(C/T)T-
39) and BSTKIIa (59-CCCGGGGAATTCC(A/G)(A/T)A(A/G)CTC-
CA(G/C)ACATC-39), that differed from PTKIa and PTKIIa were
also designed for this study. Restriction sites, underlined in the
primer sequences, were generated at the 59 (ApaI and BamHI) and
39 (XmaI and EcoRI) ends of the primer sequences.
Each cDNA source was amplified in three separate PCR reac-
tions using pairwise combinations of the PTKIa/PTKIIa, BSTKIa/
BSTKIIa, or BSTKIa/PTKIIa degenerate primers. Following 5-min
denaturation at 95°C, samples were annealed at 37°C for 1 min,
polymerized at 63°C for 2 min, and denatured at 95°C for 30 s for
40 cycles. The resulting ;200-bp PCR products were purified from
low-melting agarose (BMB), ligated into a T-vector (Invitrogen), and
transformed in Escherichia coli. Following blue/white color selec-
tion, approximately 50 transformants were picked from each of the
27 PCR reactions (3 reactions for each of nine cDNA sources) and
were subsequently transferred to gridded plates and replica plated.
In total, 1450 transformants were analyzed.
Dideoxy sequencing of 100 independent transformants was per-
formed, resulting in the identification of 14 previously described
tyrosine kinases. In order to identify and eliminate additional
isolates of these kinases from further consideration, filter lifts
representing the 1350 remaining transformants were hybridized
individually to radiolabeled DNA probes prepared from each of the
14 initially isolated kinases. Hybridization and washing were
performed as described under final washing conditions of 0.13
SSC/0.1% SDS at 70°C that were demonstrated to prevent cross-
hybridization between kinase cDNA inserts (Marquis et al., 1995).
In this manner, 887 transformants containing inserts from the 14
tyrosine kinases that had initially been isolated were identified.s of reproduction in any form reserved.
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261Protein Kinases in Mammary DevelopmentIdentifications made by colony hybridization were consistent with
those made directly by DNA sequencing.
The remaining 463 transformants were screened by PCR using
T7 and SP6 primers to identify those containing cDNA inserts of a
length expected for protein kinases. One hundred seventy-two
transformants were found to have cDNA inserts between 150 and
300 bp in length and were subjected to further analysis by succes-
sive rounds of dideoxy sequencing and colony lift hybridization.
This resulted in the identification of 27 additional protein kinases.
Individual clones were sequenced using the Sequenase version 2
dideoxy chain termination kit (U.S. Biochemical Corp.). Putative
protein kinases were identified by the DFG consensus located in
catalytic subdomain VI. DNA sequence analysis was performed
using MacVector 3.5 and the NCBI BLAST server.
RNA Preparation and Analysis
RNA was prepared by homogenization of snap-frozen tissue
samples or tissue culture cells in guanidinium isothiocyanate
supplemented with 7 ml/ml 2-mercaptoethanol followed by ultra-
centrifugation through cesium chloride as previously described
(Marquis et al., 1995; Rajan et al., 1997). Poly(A)1 RNA was
selected using oligo(dT) cellulose (Pharmacia), separated on a 1.0%
LE agarose gel, and passively transferred to a Gene Screen mem-
brane (NEN). Northern hybridization was performed as described
using 32P-labeled cDNA probes corresponding to catalytic subdo-
ains VI–IX of each protein kinase that were generated by PCR
mplification of cloned catalytic domain fragments (Marquis et al.,
995). In all cases calculated transcript sizes were consistent with
alues reported in the literature.
In Situ Hybridization
In situ hybridization was performed as described (Marquis et al.,
995). Antisense and sense probes were synthesized with the
Promega in vitro transcription system using 35S-UTP and 35S-CTP
rom the T7 and SP6 RNA polymerase promoters of a PCR
emplate containing the sequences used for Northern hybridization
nalysis.
RESULTS
Identification of Protein Kinases Expressed
in the Murine Mammary Gland
As an initial step in studying the role of protein kinases in
regulating mammary proliferation and differentiation, we
designed a screen to identify protein kinases expressed in
the mammary gland and in breast cancer cell lines. An
RT-PCR cloning strategy was employed that relies on the
use of degenerate oligonucleotide primers corresponding to
conserved amino acid motifs present within the catalytic
domain of protein tyrosine kinases (Wilks, 1989; Wilks et
al., 1989). RNA prepared from nine different sources was
used as starting material for the generation of kinase-
specific cDNA libraries. These sources included mammary
glands from 5-week-old nulliparous mice undergoing pu-
berty and parous mice at day 2 of involution, as well as a
panel of seven murine mammary epithelial cell lines. Cell
lines consisted of two nontransformed mammary epithelial
cell lines in addition to five cell lines derived from tumorsCopyright © 2000 by Academic Press. All rightnd hyperplasias that arose in the mammary glands of
MTV-neu, MMTV-c-myc, MMTV-Ha-ras, or MMTV-int2
transgenic mice (Leder et al., 1986; Muller et al., 1988,
1990; Sinn et al., 1987). Mammary tumors arising in each of
these transgenic strains have previously been demonstrated
to possess distinct and characteristic histopathologies that
have been described as a large basophilic cell adenocarci-
noma associated with the myc transgene, a small eosino-
philic cell papillary carcinoma associated with the Ha-ras
transgene, a pale intermediate cell nodular carcinoma asso-
ciated with the neu transgene, and a papillary adenocarci-
noma associated with the int-2 transgene (Cardiff and
Muller, 1993; Cardiff et al., 1991; Munn et al., 1995).
First-strand cDNA prepared from each of these sources
was independently amplified using the previously described
degenerate oligonucleotide primers, PTKI and PTKII, that
encode conserved amino acid motifs within catalytic sub-
domains VIb and IX (Hanks and Quinn, 1991; Wilks, 1991;
Wilks et al., 1989). In an effort to isolate a broad array of
protein kinases, two additional degenerate oligonucleotide
primers, BSTKI and BSTKII, which are also directed against
subdomains VIb and IX, but which differ in nucleotide
sequence, were designed for use in this screen. Degenerate
oligonucleotide primers were used in three pairwise com-
binations (PTKI/PTKII, BSTKI/BSTKII, and BSTKI/PTKII) to
amplify first-strand cDNA from each of the nine sources.
The resulting 150- to 300-bp PCR products from each
amplification were subcloned into a plasmid vector. Ap-
proximately 50 bacterial transformants from each of the 27
PCR reactions were replica plated and screened by a com-
bination of DNA sequencing and colony lift hybridization
in order to identify the protein kinase from which each
subcloned catalytic domain fragment was derived.
A total of 1450 bacterial transformants were analyzed by
this approach. Of these, greater than 70% contained protein
kinase cDNA inserts as determined by hybridization and
sequencing. Analysis of these clones resulted in the identi-
fication of 33 tyrosine kinases and 8 serine/threonine ki-
nases (Table 1). The 19 receptor tyrosine kinases and 14
cytoplasmic tyrosine kinases isolated accounted for all but
33 of the 1056 kinase-containing clones. The remaining
clones were derived from 8 serine/threonine kinases, 7 of
which were represented by a single clone each, including
each of the novel kinases isolated in this screen. Approxi-
mately half of the 41 kinases were isolated more than once,
and most of these were isolated from more than one tissue
or cell line (Table 1 and data not shown). Eight tyrosine
kinases, including Jak2, Fgfr1, EphA2, Met, Igf1r, Hck, Jak1,
and Neu, accounted for 830 (79%) of all clones analyzed
(Table 1). Conversely, 18 kinases (44%) were represented by
a single clone each, suggesting that further screening of
cDNA libraries derived from these tissues and cell lines
may yield additional kinases. The number of clones isolated
for each kinase presumably reflects a combination of
mRNA abundance and extent of homology to the oligonu-
cleotide primers used in the amplification reaction.
Three novel protein kinases were identified in thiss of reproduction in any form reserved.
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262 Chodosh et al.screen, designated Bstk1, 2, and 3. Each of these kinases
ontains the amino acid motifs characteristic of serine/
hreonine kinases (Fig. 1). Bstk1 was isolated from a mam-
ary epithelial cell line derived from a tumor that arose in
n MMTV-neu transgenic mouse and is most closely re-
ated to the SNF1 family of serine/threonine kinases. A
ull-length cDNA encoding Bstk1 has subsequently been
solated (Gardner et al., 2000b), as have partial cDNA
sequences (Korobko et al., 1997). Bstk2 and Bstk3 were each
isolated from the mammary glands of mice undergoing
early postlactational regression. Bstk2 exhibits highest ho-
mology to kinases recently identified in Saccharomyces
cerevisiae and Arabidopsis thaliana and analysis of full-
length clones encoding this kinase indicates that it repre-
sents the first vertebrate member of a new family of
mammalian protein kinases (Kurioka et al., 1998; Ligos et
l., 1998; Stairs et al., 1998). Bstk3 is most closely related to
alcium/calmodulin-dependent protein kinase I, and full-
ABLE 1
rotein Kinases Isolated from Mammary Glands and Mammary
pithelial Cell Lines
Receptor
tyrosine kinases
Nonreceptor
tyrosine kinases
Serine/threonine
kinases
xl/Ufo 6 c-Abl 5 c-Akt1 1
phA2 121 Csk 46 Mlk1 1
phA7 1 Ctk 1 Plk 26
phB3 2 c-Fes 24 A-Raf 1
gfr 1 Fyn 7 SLK 1
gfr1 126 Hck 88
lt3 1 Jak1 74
gf1r 89 Jak2 150
nsR 1 Lyn 21
-Kit 2 Prkmk3 3
et 120 c-Src 23
Novel kinases
MuSK 1 Srm 1 Bstk1 1
eu 62 Tec 1 Bstk2 1
on 10 Tyk2 4 Bstk3 1
yk 1
ie1 1
ie2 27
yro10 2
yro3 1
Note. Kinases are arranged by family and class. The number of
lones isolated for each kinase is shown on the right.Copyright © 2000 by Academic Press. All rightength isoforms have subsequently been identified in the
ouse and rat (Yokokura et al., 1997, and Gardner et al.,
000a).
Expression of Protein Kinases in Mammary
Epithelial Cell Lines
As a first step in investigating the range of expression
patterns for the 41 protein kinases isolated in this screen,
we determined kinase expression profiles in a panel of 18
murine mammary epithelial cell lines (Fig. 2). These in-
cluded 14 cell lines derived from independent tumors
arising in transgenic mice expressing either the neu, c-myc,
H-ras, or int-2 oncogenes under the control of the MMTV
LTR, 1 cell line derived from the hyperplastic mammary
epithelium of an MMTV-int-2 transgenic mouse, and 3
nontransformed, nontransgenic mammary epithelial cell
lines (Fig. 2) (Leder et al., 1986; Morrison and Leder, 1994;
Muller et al., 1988, 1990; Sinn et al., 1987). Kinase expres-
sion was also investigated in NIH3T3 fibroblasts in order to
identify those kinases that might be expressed in a
mesenchymal- or epithelial-specific manner. All cell lines
were grown under identical conditions and were harvested
while actively proliferating.
Of the 41 kinases isolated in this screen, 25 were found to
be ubiquitously expressed in the epithelial cell lines exam-
ined (Fig. 2 and data not shown). Steady-state mRNA levels
for 11 of these ubiquitously expressed kinases exhibited
relatively little variation among cell lines. These include
Tyk2, Neu, Ryk, Plk, Csk, Akt1, A-Raf, Prkmk3, and the
insulin receptor. Steady-state mRNA levels for the remain-
ing 14 ubiquitously expressed kinases varied considerably
among cell lines. These include the receptor tyrosine ki-
nases Egfr, Igf1R, Met, Tyro3, EphA2, EphA7/Hek11/Ehk3,
and EphB3/Hek2, as well as the cytoplasmic tyrosine
kinases Jak1, Jak2, c-Abl, c-Src, Lyn, and Tec and the
serine/threonine kinase SLK (Fig. 2 and data not shown).
In contrast, mRNA expression of 11 of the kinases
examined was detectable in only a subset of epithelial cell
lines. These kinases range from those that are expressed
within the majority of cell lines tested, such as Fgfr1, Fyn,
Axl, and Mlk1, to kinases that are expressed in only a small
number of these cell lines, such as Tyro10, c-Fes, c-Kit, and
Flt3 (Fig. 2 and data not shown). Within this latter group of
kinases, Ron, Srm, and Hck are expressed at detectableFIG. 1. Amino acid sequence of catalytic subdomains of novel protein kinases. Aligned amino acid sequences for isolated cDNA fragments
orresponding to catalytic subdomains VIb–IX of Bstk1, Bstk2, and Bstk3.s of reproduction in any form reserved.
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263Protein Kinases in Mammary Developmentlevels in only a single mammary epithelial cell line each
(Fig. 2 and data not shown). Interestingly, both EphB3 and
c-Kit are preferentially expressed in tumor cell lines derived
from MMTV-neu and MMTV-Ha-ras transgenic animals
ompared to cell lines derived from MMTV-c-myc and
MTV-int-2 transgenic animals. Oncogene-associated pat-
erns of expression have also been observed for Bstk1 and
FIG. 2. Protein kinase expression in murine breast cancer cell line
or mammary hyperplasias (HBI2) arising in transgenic animals exp
gland, as indicated. Northern hybridization analysis of 6 mg of poly(A
robes specific for each of the kinases indicated is shown. Origin
ontransformed (Non-Tx) (NMuMG, HC11, and CL-S1), MMTV-in
6MB9a), MMTV-neu (SMF, NAF, NF639, NF11005, and NK-2), aCopyright © 2000 by Academic Press. All rightstk3 (Gardner et al., unpublished results). Similar patterns
f expression in this panel of cell lines have previously been
eported for protein tyrosine phosphatase e and other mol-
cules (Elson and Leder, 1995; Morrison and Leder, 1994).
Additional patterns of expression that presumably reflect
ell-type specificity were observed. For instance, Mlk1 is
xpressed in all cell lines except for NIH3T3 fibroblasts and
nsformed cell lines were derived from mammary adenocarcinomas
ng the int-2, c-myc, neu, or v-Ha-ras oncogenes in the mammary
NA from actively growing murine cell lines hybridized with cDNA
he cell lines from left to right are as follows: NIH3T3 fibroblast,
HBI2 and 1128), MMTV-c-myc (8Ma1a, MBp6, M1011, M158, and
MTV-Ha-ras (AC816, AC711, and AC236).s. Tra
ressi
)1 R
s of t
t-2 (s of reproduction in any form reserved.
m
c
w
d
f
264 Chodosh et al.for MBp6, the sole mammary cell line that does not express
the epithelial marker cytokeratin 18. The resulting infer-
ence that Mlk1 expression is epithelial-specific was subse-
quently confirmed by in situ hybridization (Fig. 8). By
comparison with Mlk1, Tyro10 exhibited an inverse pattern
of expression with steady-state levels of mRNA detectable
only in NIH3T3, MBp6, and the int-2-initiated tumor cell
line, 1128, suggesting that this kinase is preferentially
expressed in stromal compared to epithelial cells. This
hypothesis was also confirmed by in situ hybridization
(Figs. 10E–10H). Similarly, expression in mammary epithe-
lial cell lines was detected neither for Tie1 nor Tie2, each of
which has been shown to be expressed in an endothelial-
specific manner, nor for MuSK, whose expression is re-
stricted to muscle (Ganju et al., 1995; Partanen et al., 1992;
Sato et al., 1993; Valenzuela et al., 1995b).
Surprisingly, expression of the receptor tyrosine kinases
EphB3/Hek2 and EphA7/Hek11/Ehk3 was demonstrated in
all of the mammary epithelial cell lines examined, despite
the fact that expression of these kinases has been reported
to be restricted primarily to the central nervous system
(Aasheim et al., 1997; Adams et al., 1999; Bergemann et al.,
1998; Fox et al., 1995; Krull et al., 1997; Valenzuela et al.,
1995a). Similarly, despite previous reports that expression
of each of the nonreceptor tyrosine kinases Lyn, Tec, and
Hck is restricted primarily to cells of hematopoietic origin,
Lyn and Tec expression was detected in all 18 mammary
epithelial cell lines tested, and Hck expression was detected
in 2 mammary tumor cell lines (Fig. 2 and data not shown)
(Kluppel et al., 1997; Quintrell et al., 1987; Sato et al., 1994;
Umemori et al., 1992; Yi et al., 1991; Ziegler et al., 1987).
Interestingly, Lyn has been shown to specifically bind and
phosphorylate Tec in hematopoietic cells in vivo, suggest-
ing that Tec is a downstream effector of Lyn (Mano et al.,
1994, 1996). Our finding that Lyn and Tec are also coex-
pressed in mammary epithelial cells suggests that this
signaling pathway may function in mammary epithelial
cells as well as in cells of hematopoietic origin.
Expression of Protein Kinases during Postnatal
Mammary Development
Since the expression of regulatory molecules is frequently
controlled at the level of transcription, we analyzed the
temporal pattern of expression during postnatal mammary
development for each of the protein kinases isolated in this
screen. Kinase expression was determined in mammary
glands harvested from male FVB mice and from female mice
at nine time points corresponding to developmental mile-
stones encompassing puberty (2, 5, and 10 weeks of age),
pregnancy (days 7, 14, and 20), lactation (day 9), and
postlactational regression (days 2 and 7). Replicate Northern
blots containing poly(A)1 mRNA from each of these develop-
ental stages were hybridized with probes prepared from
atalytic domain fragments corresponding to each kinase.
As an initial control, Northern blots were hybridized
ith probes for the genes encoding b-actin, Gapdh, and
cytokeratin 18 (Fig. 3). The resulting patterns were consis-Copyright © 2000 by Academic Press. All righttent with previous observations that steady-state levels of
mRNA for many genes appear to decline during lactation
and, to a lesser extent, late pregnancy and early postlacta-
tional regression (Marquis et al., 1995; Rajan et al., 1997).
Since the expression of b-actin, gapdh, and cytokeratin 18
does not decrease on a per-cell basis when assayed by in situ
hybridization (J. Hartman, unpublished results), this phe-
nomenon most likely results from a dilutional effect due to
the extraordinary increase in milk protein gene expression
that occurs during lactation. Expression levels for each
kinase were therefore quantitated by phosphorimager anal-
ysis and normalized to b-actin in order to correct for these
dilutional effects.
A wide range of developmental patterns of gene expres-
sion was observed for the kinases surveyed in this study.
FIG. 3. Expression of control genes during mammary gland devel-
opment. Northern hybridization analysis of mRNA expression is
shown for cytokeratin 18, Gapdh, and b-actin, during postnatal
evelopmental of the murine mammary gland. 3 mg of poly(A)1
RNA isolated from the mammary glands of FVB mice at the
indicated time points was hybridized to 32P-labeled cDNA probes
or the genes indicated. The smear of poly(A)1 RNA beneath the
28S ribosomal RNA band is shown as a loading control. Note the
apparent decrease in gene expression levels during lactation for all
three genes, despite the similar amount of poly(A)1 present. Origins
of the mammary developmental time points are as follows: adult
male; nulliparous females at 2 weeks (prior to puberty), 5 weeks
(during puberty), and 10 weeks (following puberty) of age; gravid
females at day 7, day 14, and day 20 of pregnancy; day 9 of lactation;
and day 2 and day 7 of postlactational regression.s of reproduction in any form reserved.
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265Protein Kinases in Mammary DevelopmentBased on the assumption that kinases exhibiting distinctive
patterns of regulation during particular stages of mammary
development may be involved in regulating specific devel-
opmental events, we grouped these genes according to
similarities in their developmental expression profiles. This
approach revealed an ordered set of expression profiles that
suggested the coordinated regulation of protein kinases
acting at different stages of mammary development. While
the observation that a particular kinase is expressed in a
developmentally regulated manner does not prove that the
kinase plays a role in development, the spatial and temporal
patterns of expression for a gene often provide important clues
to its biological function. Similarly, the identification of
kinases with common developmental expression profiles may
identify kinases whose developmental functions are related.
Kinase Expression during Ductal Morphogenesis
Prior to the onset of puberty at 2 weeks of age, the
mammary glands of female FVB mice consist of a rudimen-
tary epithelial tree originating from the nipple and penetrat-
ing a short distance into a mammary fat pad composed of
fibroblasts and adipocytes. Following the onset of puberty
at approximately 3 weeks of age, increased levels of ovarian
FIG. 4. Expression of protein kinases during ductal morphogenes
postnatal development of the murine mammary gland is shown. 3
he indicated time points was hybridized to 32P-labeled cDNA probe
points are as in Fig. 3. Phosphorimager analysis of Northern blots is
normalized to b-actin expression to correct for dilutional effects d
pregnancy and lactation. Expression levels normalized to b-actin aCopyright © 2000 by Academic Press. All rightteroids trigger the formation of club-shaped terminal end
uds at the ends of growing mammary ducts. These are
omposed of highly proliferative, relatively undifferentiated
pithelial cells that give rise to the differentiated cell types
f the mammary tree, and the appearance of these struc-
ures marks the onset of the rapid cellular proliferation
haracteristic of ductal morphogenesis. By 5 weeks of age,
ver half of the mammary fat pad is filled with epithelial
ucts as a consequence of ongoing ductal elongation and
ranching. The completion of ductal morphogenesis occurs
t 10 weeks of age when most terminal end buds have
eached the edge of the fat pad and have regressed.
Unlike many strains of mice in which males lack mam-
ary glands, mammary glands are present in male FVB
ice and can be studied. This represents one advantage of
tudying mammary development in this strain of mice.
ccordingly, several protein kinases, including c-Abl, Met,
sk, hck, c-Src, Fgfr1, Axl, Jak1, Jak2, Tyro3, Mlk1, and
tk, exhibited similar levels of expression in the mammary
lands of adult male mice and 2-week-old female mice (Figs.
–9). Presumably, this reflects the fact that both adult
ales and prepubescent females have low levels of circu-
ating 17b-estradiol and possess only a rudimentary mam-
mary epithelial tree. Conversely, levels of expression for
orthern hybridization analysis of Tie1 and Ron expression during
poly(A)1 RNA isolated from the mammary glands of FVB mice at
the genes indicated. Origins of the mammary developmental time
n for Tie1 and Ron. Protein kinase expression was quantitated and
large-scale increases in milk protein gene expression during late
own relative to adult virgin (10 wk).is. N
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266 Chodosh et al.Tie1, Ron, SLK, and Plk differed in the mammary glands of
dult male and 2-week-old female mice, potentially reflect-
ng different levels of androgens, different diets (e.g. chow
ersus milk), or other age-specific or gender-specific differ-
nces between these two groups of mice. Several protein
inases, including Ron, Met, c-Abl, Axl, Jak1, Tyro3, and
Mlk1, exhibited an increase in expression in the mammary
glands of nulliparous mice between 2 and 5 weeks of age
concomitant with the onset of ductal morphogenesis (Figs.
4–7). This pattern may reflect increases in circulating
steroid hormone levels, increases in cellular proliferation,
or increases in epithelial cell content (as reflected by the
expression pattern of cytokeratin 18), that occur at the
onset of puberty or changes in diet that occur at weaning
(Fig. 3). Thus, similarities and differences in diet, hormonal
environment, cellular proliferation, cellular differentiation,
and epithelial content may account for changes in kinase
expression patterns observed at different developmental
stages.
The tyrosine kinases Tie1, Ron, and Srm each exhibited
unique expression patterns with highest steady-state levels
of mRNA occurring during the development of the virgin
gland (Fig. 4 and data not shown). The endothelial-specific
receptor tyrosine kinases Tie1 and Tie2 were each found to
be expressed at highest levels just prior to the onset of
puberty in 2-week-old female mice (Fig. 4 and data not
shown). A similar pattern of developmental expression was
observed for the nonreceptor tyrosine kinase, Srm (data not
shown). Little is currently known regarding the physiolog-
ical state of the prepubescent mammary gland. However,
since Tie1 and Tie2 are required for the normal growth and
organization of blood vessels, as well as for establishing the
structural integrity of the vascular endothelium (Sato et al.,
1995), this observation suggests the possibility that changes
in endothelial cells or in the vasculature of the mammary
gland may precede the rapid ductal growth that begins at
puberty.
In contrast to Tie1 and Tie2, expression of the receptor
yrosine kinase Ron increases progressively during ductal
orphogenesis, is downregulated at the onset of preg-
ancy, and remains low throughout the remainder of
ostnatal mammary development (Fig. 4). Since the li-
and for Ron, Macrophage-Stimulating Protein, is a mo-
tility factor that promotes integrin-dependent epithelial
cell migration (Wang et al., 1996), it is plausible to
hypothesize that Ron may contribute to the rapid epithe-
lial migration characteristic of ductal morphogenesis.
Consistent with this hypothesis, activation of Ron in
epithelial cell lines results in enhanced proliferation, mi-
gration, and invasion through reconstituted basement mem-
branes (Santoro et al., 1996; Tamagnone and Comoglio, 1997;
Wang et al., 1996). Moreover, Ron is overexpressed in a subset
of human primary breast carcinomas (Maggiora et al., 1998).
Together, these observations suggest a potential role for Ron
in epithelial invasion during both normal and neoplastic
mammary development.Copyright © 2000 by Academic Press. All rightKinase Expression during Pregnancy and Lactation
Early in pregnancy, alveolar epithelial cells proliferate
rapidly to form alveolar buds in response to rising levels of
estrogens and progesterone. Alveolar cell proliferation oc-
curs primarily during the first half of pregnancy, whereas
alveolar differentiation occurs in a graded and progressive
manner throughout pregnancy. This culminates in the
withdrawal of epithelial cells from the cell cycle late in
pregnancy concomitant with their terminal differentiation.
Lactation, the final stage of lobuloalveolar development,
occurs following parturition in the hormonal setting of high
prolactin levels and declining estrogen and progesterone
levels. The marked cellular changes that occur in the
mammary gland during pregnancy and lactation are re-
flected on a molecular level by the temporally ordered
expression of different milk protein genes (Robinson et al.,
995). Each of the members of this class of genes undergoes a
aximal increase in expression at a characteristic time during
regnancy and can be classified as an early, intermediate, or
ate marker for mammary epithelial differentiation.
Similar to milk protein genes, clustering of protein ki-
ases on the basis of similarities in their developmental
xpression patterns also yields an ordered temporal set of
xpression profiles throughout pregnancy and lactation
Figs. 5 and 6). Consistent with the dramatic changes that
ake place in the mammary gland during these developmen-
al stages, over half of all kinases examined were regulated
uring lobuloalveolar development. These were grouped
nto two sets based on whether kinases were upregulated or
ownregulated during pregnancy.
Seventeen kinases were found to be upregulated during
regnancy, and examination of their temporal expression
rofiles indicates that successive waves of kinase expres-
ion occur at each stage of lobuloalveolar development (Fig.
). Ten kinases, including EphA7, SLK, c-Abl, Met, Lyn,
-Kit, and Egfr, exhibited maximal upregulation during
arly pregnancy. A smaller number of kinases exhibited
aximal upregulation during the remainder of lobuloalveo-
ar development, including mid-pregnancy (Hck) as well as
ate pregnancy and lactation (c-Akt1 and c-Fes).
Expression of the receptor tyrosine kinase EphA7 in
issues of adult mice has principally been described in the
entral nervous system. In this study, we detected EphA7
xpression both in mammary epithelial cell lines and in the
ammary gland, where it is maximally upregulated during
arly pregnancy. Interestingly, during fetal development
phA7 is expressed in bone marrow pro-B and pre-B cells,
ut not in more mature fetal B-lineage cells or in any
-lineage cells of the adult (Aasheim et al., 1997). In light of
he similarities between postnatal mammary development
nd the embryonic development of other organs, it is
ossible that EphA7 may play a lineage-specific or
ifferentiation-dependent role in the mammary gland dur-
ng early pregnancy.
The receptor tyrosine kinase Met has previously been
mplicated in mammary development by virtue of its abil-
ty to stimulate branching morphogenesis and lumen for-s of reproduction in any form reserved.
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267Protein Kinases in Mammary Developmentmation in mammary epithelial cells (Niemann et al., 1998;
Tsarfaty et al., 1992). In addition, some studies have sug-
gested that c-Met is overexpressed in a subset of human
breast cancers, and the mammary glands of transgenic mice
FIG. 5. Expression of protein kinases upregulated during pregnanc
ostnatal development of the murine mammary gland is shown fo
poly(A)1 RNA isolated from the mammary glands of FVB mice at th
he genes indicated. Northern blots are arranged with kinases exhib
pregulation late in pregnancy at the bottom. Origins of the mamm
f selected Northern blots are shown on the right. Expression leveCopyright © 2000 by Academic Press. All rightxpressing the tpr-met oncogene develop hyperplastic al-
eolar nodules and carcinomas (Jin et al., 1997; Liang et al.,
1996). Nevertheless, a role for Met in mammary develop-
ment has not been directly demonstrated.
orthern hybridization analysis of protein kinase expression during
election of kinases that are upregulated during pregnancy. 3 mg of
dicated time points was hybridized to 32P-labeled cDNA probes for
upregulation early in pregnancy at the top and kinases exhibiting
evelopmental time points are as in Fig. 3. Phosphorimager analyses
rmalized to b-actin are shown relative to adult virgin (10 wk).y. N
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268 Chodosh et al.Unlike other kinases analyzed in this study, both c-Akt1
nd c-Fes were maximally upregulated in the mammary
land during lactation. Akt1 has recently been shown to
rovide survival signals in response to a variety of growth
actors and cytokines, and the Akt pathway is suppressed by
he PTEN tumor suppressor gene. The further finding that
erm-line mutations in PTEN predispose women to breast
ancer suggests that Akt1 may be a prosurvival signal in the
ammary epithelium as well (Li et al., 1997, 1998; Liaw et
al., 1997; Stambolic et al., 1998; Steck et al., 1997). Consis-
tent with this hypothesis, Akt1 is expressed at high levels
FIG. 6. Expression of protein kinases downregulated during pre
uring postnatal development of the murine mammary gland is sho
mg of poly(A)1 RNA isolated from the mammary glands of FVB
probes for the genes indicated. Origins of the mammary developm
Northern blots are shown on the right. Expression levels normalizCopyright © 2000 by Academic Press. All rightin human breast cancer cell lines. Similarly, while c-Fes
expression has not previously been reported in the mam-
mary gland, this kinase has been implicated in the induc-
tion of terminal myeloid differentiation and in promoting
the survival of differentiating myeloid cells (Ferrari et al.,
1994; Manfredini et al., 1997; Yu et al., 1989). The high
levels of Akt1 and c-Fes expression observed in the mam-
mary gland during lactation suggest that these kinases may
play a role in propagating survival signals in terminally
differentiated cells. As such, the rapid downregulation of
Akt1 and c-Fes expression at parturition may contribute to
cy. Northern hybridization analysis of protein kinase expression
or a selection of kinases that are downregulated during pregnancy.
at the indicated time points was hybridized to 32P-labeled cDNA
time points are as in Fig. 3. Phosphorimager analyses of selected
b-actin are shown relative to adult virgin (10 wk).gnan
wn f
mice
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269Protein Kinases in Mammary Developmentthe onset of large-scale apoptosis at day 2 of postlactational
involution. Such a model is consistent with the hypothesis
that terminally differentiated cells are dependent on sur-
vival signals from hormones and growth factors to prevent
death (Wyllie et al., 1992).
Ten protein kinases were found to be downregulated in
the mammary gland during pregnancy. In most cases, no
marked changes in expression were observed until day 14 of
pregnancy. However, for each kinase downregulation per-
sisted throughout late pregnancy, lactation, and early post-
lactational regression (Fig. 6). The function of most of the
downregulated kinases in mammary development is un-
known. The majority of downregulated tyrosine kinases are
growth factor receptors. These include Fgfr1, Axl, and the
nsulin receptor, each of which appears to mediate mito-
enic responses in mammary epithelial cells. Overexpres-
ion of Fgfr1 and of the insulin receptor has been described
n subsets of human breast cancers (Adnane et al., 1991;
golini et al., 1999; Webster et al., 1996). Conversely,
ownregulation of mitogenic growth factor pathways dur-
ng mid- and late pregnancy may be required for the
ithdrawal of epithelial cells from the cell cycle that
ccompanies terminal differentiation. This hypothesis is
onsistent with the finding that downregulation of Fgfr-
ediated signaling is required for the terminal differentia-
ion of myogenic cells during avian development (Itoh et
l., 1996).
Alternately, changes in the expression of some receptor
yrosine kinases, such as the insulin receptor, may reflect
he marked metabolic changes that occur in mammary
land during pregnancy.
FIG. 7. Expression of protein kinases during postlactational inv
during postnatal development of the murine mammary gland is sh
oly(A)1 RNA isolated from the mammary glands of FVB mice at th
he genes indicated. Origins of the mammary developmental time
yro3 and Ctk are shown on the right. Expression levels normalizCopyright © 2000 by Academic Press. All rightKinase Expression during Postlactational Involution
Immediately following weaning, secretory alveoli rapidly
involute as the majority of mammary epithelial cells die in
the apoptotic process of postlactational regression or invo-
lution. Cell death begins within 2 days following weaning,
and by day 7 of postlactational involution, intensive remod-
eling of the mammary epithelium, stroma, and extracellu-
lar matrix is well underway.
Three protein kinases identified in this screen were found
to be upregulated in the involuting mammary gland (Fig. 7).
Expression of the receptor tyrosine kinase Tyro3 is dramati-
ally upregulated in the mammary gland at day 2 of invo-
ution, yet returns to preregression levels by day 7. Since
yro3 has been proposed to play a role in the growth and
remodeling of the central nervous system, it is possible that
it plays an analogous role in the mammary gland (Lai et al.,
1994; Stitt et al., 1995).
Like Tyro3, Mlk1 is also maximally upregulated in the
mammary gland at day 2 of involution (Fig. 7). The devel-
opmental expression profiles of Mlk1 and Tyro3 share
dditional similarities as each kinase undergoes a modest
nitial upregulation in the mammary glands of nulliparous
ice between 2 and 5 weeks of age and is further upregu-
ated at the onset of pregnancy.
The developmental pattern of Mlk1 expression was fur-
her investigated by in situ hybridization (Fig. 8). This
evealed that Mlk1 is expressed in the mammary gland in
n epithelial-specific manner, as was predicted based on the
imilarity of its expression pattern in cell lines to that of
ytokeratin 18. During puberty, Mlk1 is preferentially ex-
on. Northern hybridization analysis of protein kinase expression
for protein kinases that are upregulated during involution. 3 mg of
dicated time points was hybridized to 32P-labeled cDNA probes for
ts are as in Fig. 3. Phosphorimager analyses of Northern blots for
b-actin are shown relative to adult virgin (10 wk).oluti
own
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270 Chodosh et al.FIG. 8. Spatial expression of Mlk1 during mammary development. In situ hybridization analysis of Mlk1 expression during postnatal
ammary development is shown. Bright-field (left) and dark-field (right) photomicrographs of mammary gland sections from female mice
t 6 weeks of age (A–D), 16 weeks of age (E and F), day 7 of pregnancy (G and H), and day 2 of postlactational involution (I and J) hybridized
ith an 35S-labeled Mlk1-specific antisense probe. No signal over background was detected in serial sections hybridized with a sense Mlk1
robe. Exposure times were identical for all dark-field photomicrographs to illustrate changes in Mlk1 expression during pregnancy. al,
lveoli; d, duct; lo, secretory lobule; st, adipose stroma; teb, terminal end bud. Original magnification 5003.
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271Protein Kinases in Mammary Developmentpressed in epithelial cells of terminal end buds compared to
ducts (Fig. 8, cf. 8B and 8D). This finding may explain the
upregulation of Mlk1 observed in the mammary glands of
5-week-old mice. In situ hybridization further revealed that
the modest upregulation of Mlk1 expression that occurs
during pregnancy is due to preferential induction of Mlk1
expression in developing alveoli compared to ducts, and
also confirmed the dramatic upregulation of this kinase in
involuting alveoli at day 2 of regression. The preferential
expression of Mlk1 in specific structures within the epithe-
lial compartment, such as terminal end buds and develop-
ing alveoli, demonstrates that the expression of this kinase
is regulated spatially as well as temporally during mam-
mary development.
In contrast to Tyro3 and Mlk1, expression of the Csk-
related cytoplasmic tyrosine kinase Ctk remains low
throughout virgin development and pregnancy (Fig. 7).
Induction of Ctk expression is initially observed during
lactation, with maximal upregulation occurring at day 7 of
involution. Ctk expression has previously been described
only in the brain (Brinkley et al., 1995). Together, the
developmental patterns of expression observed for Tyro3,
Mlk1, and Ctk suggest that these kinases may play a role in
the dramatic changes that occur in the mammary gland
during involution.
Proliferation-Dependent Patterns of Kinase
Expression
An intriguing pattern of developmental expression was
observed for the mammalian polo-like kinase, Plk. Plk
expression is maximally upregulated in the mammary
gland at day 7 of pregnancy, with a progressive decline in
expression observed thereafter (Fig. 9). No expression was
FIG. 9. Expression of protein kinases as a function of proliferation.
uring postnatal development of the murine mammary gland is sh
ice at the indicated time points was hybridized to 32P-labele
evelopmental time points are as in Fig. 3. Phosphorimager analys
ormalized to b-actin are shown relative to adult virgin (10 wk).Copyright © 2000 by Academic Press. All rightetected during lactation. Smaller increases in Plk expres-
ion were noted in the mammary glands of 5-week-old
ulliparous animals. The observation that the upregulation
f Plk expression coincides with peak alveolar proliferation
ates during early pregnancy, as well as previous observa-
ions that Plk expression is cell cycle-regulated (Lee et al.,
995), suggested that the developmental pattern of expres-
ion of this kinase reflects proliferative events in the
ammary gland. This hypothesis is supported by the
arked similarities in the expression profiles of Plk, cyclin
, and cyclin D1 (Fig. 9). As such, these findings strongly
uggest that the temporal profile of Plk expression reflects
ncreases in mitotic activity that occur in the mammary
land during puberty and early pregnancy. Consistent with
his hypothesis, the developmental expression of Plk in the
mammary gland is spatially restricted to proliferating cel-
lular compartments, particularly in terminal end buds dur-
ing puberty and alveolar buds during pregnancy (data not
shown).
Spatial Regulation of Kinase Expression
In addition to the diverse temporal patterns of expression
observed for the kinases analyzed in this study, diverse
spatial patterns of expression were also observed. Similar to
Mlk1 and Plk, the serine/threonine kinase SLK is upregu-
ated in the mammary epithelium at day 7 of pregnancy
Figs. 5, 7–9, and 10A–10D, and data not shown). However,
hereas Mlk1 and Plk are preferentially expressed in alveoli
ompared to ducts at this stage of development, SLK up-
egulation occurs in both ducts and alveoli. This observa-
ion suggests that upregulation of SLK expression may
ccur in response to signals that are distributed throughout
hern hybridization analysis of protein kinase and cyclin expression
. 3 mg of poly(A)1 RNA isolated from the mammary glands of FVB
NA probes for the genes indicated. Origins of the mammary
the Northern blot for Plk is shown on the right. Expression levelsNort
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272 Chodosh et al.the epithelium, rather than to changes specific to a subset
of epithelial cells within a particular compartment.
Unlike the majority of kinases analyzed in this study,
FIG. 10. Spatial expression of SLK and Tyro3 during mammary de
xpression during postnatal mammary development. Bright-field (l
rom nulliparous female mice at 16 weeks of age (A and B) or day 7 o
or SLK or Tyro3. Stromal cells at the edge of the mammary fat pad
n serial sections hybridized with sense SLK or Tyro3 control probes
o illustrate changes in expression during pregnancy. al, alveoli; d,
ells expressing Tyro3. Cells without detectable Tyro3 expressionCopyright © 2000 by Academic Press. All rightxpression of the receptor tyrosine kinase Tyro10 was
estricted to the stroma of the mammary gland (Figs.
0E–10H). This cell type-specificity was predicted based on
ment. In situ hybridization analysis of SLK (A–D) and Tyro3 (E–H)
nd dark-field (right) photomicrographs of mammary gland sections
gnancy (C–H) hybridized with 35S-labeled antisense probes specific
hown in panels G and H. No signal over background was detected
osure times were identical for dark-field photomicrographs for SLK
; lu, lumen of epithelial duct; st, adipose stroma. Arrows indicate
ndicated by arrowheads. Original magnification 5003.velop
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273Protein Kinases in Mammary Developmentour initial finding that Tyro10 is preferentially expressed in
cell lines that are negative for expression of the epithelial
marker cytokeratin 18 (Fig. 2). Within the mammary gland,
Tyro10 is expressed in regions immediately surrounding
epithelial structures (Fig. 10E and 10F) as well as in regions
at the periphery of the mammary fat pad (Fig. 10G and 10H).
Interestingly, Tyro10 expression is strikingly heteroge-
eous in stromal cells, suggesting that the expression of
his kinase may be restricted to a specific stromal cell type.
DISCUSSION
We have isolated 33 tyrosine kinases and 8 serine/
threonine kinases that are expressed during the postnatal
development of the murine mammary gland. Since tran-
scription is one of the key steps at which gene expression is
regulated, we chose to examine the mRNA expression of
each of these kinases in a panel of transgenic mammary
epithelial cell lines and in the mammary gland during
multiple stages of development. Although protein kinases
are typically regulated at the posttranslational level, the
majority of kinases analyzed in this study were also found
to be developmentally regulated at the mRNA level. Ki-
nases were subsequently clustered into groups based on
similarities in these expression patterns as a first step in
drawing inferences about developmental processes in
which they might be involved. In this manner, the panel of
protein kinases identified in this study was used to produce
a temporal map of developmental gene expression for the
mammary gland.
While the temporal patterns of gene expression observed
for the protein kinases surveyed in this study were diverse,
application of a clustering approach revealed an ordered set
of expression profiles in which successive waves of kinase
expression occur during development. This finding suggests
that a coordinated program of protein kinase expression
exists that may play a role in regulating the cascade of
events constituting mammary development.
A wide range of kinases was isolated in this study,
including members of multiple receptor tyrosine kinase,
cytoplasmic tyrosine kinase, and serine/threonine kinase
subfamilies. A subset of the kinases that were identified in
mammary gland samples was not expressed in the mam-
mary epithelial cell lines tested, presumably as a result of
their expression in a nonepithelial cell type. In contrast,
virtually all of the kinases identified in mammary tumor
cell lines were also found to be expressed in the mammary
gland during development. This observation suggests that
the expression of kinases detected in mammary epithelial
cell lines is not merely a consequence of malignant trans-
formation, nor of culture conditions, but rather suggests
that these molecules may play a role in the normal physi-
ology of the mammary gland. Of note, the kinase expression
patterns observed in the panel of mammary epithelial cell
lines tested were markedly heterogeneous, with dissimilar
expression patterns observed even for kinases that dis-
played similar expression profiles during development. WeCopyright © 2000 by Academic Press. All rightonclude that kinase expression patterns in mammary
land samples and in epithelial cell lines reflect distinct
spects of mammary biology.
In recent cDNA microarray experiments in the yeast S.
erevisiae, more than 60% of characterized genes that were
ound to be regulated in a cell cycle-dependent manner were
lready known to have functions related to the cell cycle
Cho et al., 1998). Thus, while the finding that expression of
particular kinase is developmentally regulated does not
rove that the kinase plays a role in development, the
patial and temporal patterns of expression for a gene may
rovide important clues to its biological role. Kinases
xhibiting distinctive patterns of regulation during mam-
ary development may, in fact, be involved in controlling
r mediating developmental events. Similarly, the identifi-
ation of kinases that share developmental expression pro-
les may also identify kinases whose developmental func-
ions are related.
The vast majority of protein kinases isolated in this
creen currently have no recognized role in mammary
evelopment. Since poorly characterized genes whose ex-
ressions fluctuate in parallel may not only be regulated by
arallel pathways, but also may function in parallel path-
ays, RNA expression patterns may provide a straightfor-
ard means of gaining insight into roles played in mam-
ary development. As such, extrapolation may yield
nsights into the role in mammary development played by
inases whose functions have been elucidated in other
issues. Conversely, insight into the function of kinases
acking previously described roles in murine development
ay be gained by extrapolation from patterns of kinase
xpression during mammary development.
The expression of a number of kinases isolated in our
tudy has previously been reported to be restricted to
issues other than the mammary gland. Such kinases in-
lude EphB3, EphA7, Ctk, Lyn, Hck, and Tec. Each of these
kinases is also expressed in the mammary epithelial cell
lines tested. Our observation that the majority of these
kinases are developmentally regulated in the mammary
gland suggests that these molecules have additional unrec-
ognized functions. It will be of great interest to determine
whether the functions of these kinases in mammary devel-
opment are analogous to their functions in other tissues.
RT-PCR screens designed to identify protein kinases
expressed in mammary carcinomas or in the mammary
gland have previously been reported by three groups: Leh-
tola et al. isolated 10 protein kinases from the human breast
cancer cell line MCF-7; Cance et al. isolated 25 protein
kinases from a human breast carcinoma and from the
human breast cancer cell line 600PEI; and Andres et al.
isolated 24 protein kinases from murine mammary glands
(Andres et al., 1995; Cance et al., 1993; Lehtola et al., 1992).
In total, these screens resulted in the identification of 43
protein kinases, 21 of which were also identified in the
present study. In addition to these previously isolated
kinases, our screen has resulted in the identification of an
additional 20 kinases expressed in the mammary gland,s of reproduction in any form reserved.
A274 Chodosh et al.bringing the total number of kinases identified in this
manner to 63.
In aggregate, beyond providing clues to the regulation of
different stages of postnatal mammary development by
specific protein kinases, approaches similar to those taken
here should prove useful in identifying sequences of events,
as well as coherent regulatory patterns, in mammary devel-
opment. Moreover, by analogy with hematopoiesis, certain
kinases may be expressed in the mammary gland in a
lineage-restricted manner and may thereby serve as useful
markers for epithelial or stromal cell subtypes. As such, it is
likely that the composite spatial and temporal pattern of
kinase expression in the mammary gland at any given
developmental stage can provide important information
regarding its physiological state and should provide insight
into the molecules that regulate different stages of postna-
tal mammary development. Ultimately, the finding that
most kinases expressed in the mammary gland are develop-
mentally regulated suggests that the array of kinases par-
ticipating in the regulation of mammary development is
considerably broader than currently appreciated.
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